New funding for an innovative UB program that trains Zimbabwe’s clinician scientists and translational pharmacologists will bring additional health care professionals and researchers to Buffalo to be trained to fight the war on AIDS in Zimbabwe.
UB’s HIV Clinical Pharmacology Research Program in the School of Pharmacy and Pharmaceutical Sciences and its program with the University of Zimbabwe has received a $1.5 million National Institutes of Health Fogarty International Center grant; last month the program was awarded a supplement as part of the American Recovery and Reinvestment Act (ARRA) of 2009.
“This is a major advance,” says Gene D. Morse, associate director of the translational pharmacology core in UB’s New York State Center of Excellence in Bioinformatics and Life Sciences, and a professor in UB’s pharmacy school.
He noted that this was the first time the UB-UZ program, which began in 2002, has received a Fogarty grant, NIH’s program for funding international research.
“The ARRA funds will help introduce to Zimbabwe electronic information technology in conducting HIV/AIDS clinical research,” he said.
